Elegant antibody nanoparticles override immunological tolerance of tumors

(Chinese Academy of Sciences Headquarters) Scientists from the Shanghai Institute of Materia Medica (SIMM) of the Chinese Academy of Sciences have developed a tumor enzymatic microenvironment-activatable antibody nanoparticle for robust cancer immunotherapy.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news